Translator Disclaimer
1 June 2001 17β-Estradiol Modulates Prostaglandin E2 Release from Human Amnion-Derived WISH Cells
Author Affiliations +
Abstract

In human amnion-derived WISH cells [3H]estradiol-17β binding sites are not detectable, but they become measurable in cells exposed to cAMP elevating agents such as forskolin or Ro 20-1724. In cells unexposed to these drugs, 17β-estradiol stimulates prostaglandin (PG)E2 release but exerts an evident inhibitory effect in cells exposed to Ro 20-1724. Both stimulatory and inhibitory actions are inhibited by the estrogen receptor antagonist, tamoxifen, by cell pretreatment with cycloheximide, or when the hormone is bound to BSA. Our data demonstrate for the first time that 1) 17β-estradiol modulates PGE2 release from WISH cells, interacting with specific intracellular receptors and probably evoking new protein synthesis, and 2) WISH cell responsiveness to 17β-estradiol seems to be modulated by cAMP, whose levels are significantly increased by the steroid hormone in the presence of Ro 20-1724. The nucleotide is presumably responsible for the enhacement of hormone receptor availability and for the inhibition of PGE2 release observed in the presence of Ro 20-1724.

Barbara Pavan, Carla Biondi, Maria Enrica Ferretti, Laura Lunghi, and Guglielmo Paganetto "17β-Estradiol Modulates Prostaglandin E2 Release from Human Amnion-Derived WISH Cells," Biology of Reproduction 64(6), 1677-1681, (1 June 2001). https://doi.org/10.1095/biolreprod64.6.1677
Received: 3 August 2000; Accepted: 1 January 2001; Published: 1 June 2001
JOURNAL ARTICLE
5 PAGES

This article is only available to subscribers.
It is not available for individual sale.
+ SAVE TO MY LIBRARY

SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top